Advertisement
Screener

ROCKWELL MEDICAL, INC. (RMTI) Investment Income, Net

ROCKWELL MEDICAL, INC. Investment Income, Net

ROCKWELL MEDICAL, INC. (RMTI) reported Investment Income, Net of $40.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeNet · last filed 2026-08-13

  • ROCKWELL MEDICAL, INC. investment income, net for the quarter ending 2026-06-30 was $40.00K, a 42.03% decline year-over-year.
  • ROCKWELL MEDICAL, INC. investment income, net for the quarter ending 2026-03-31 was $37.00K, a 43.94% decline year-over-year.
  • ROCKWELL MEDICAL, INC. investment income, net for the quarter ending 2025-12-31 was $44.00K, a 51.72% increase year-over-year.
  • ROCKWELL MEDICAL, INC. investment income, net for the quarter ending 2025-09-30 was $55.00K, a 83.33% increase year-over-year.
  • ROCKWELL MEDICAL, INC. investment income, net for fiscal 2025 was $234.00K, a 154.35% increase from fiscal 2024.
  • ROCKWELL MEDICAL, INC. investment income, net for fiscal 2024 was $92.00K, a 56.40% decline from fiscal 2023.
  • ROCKWELL MEDICAL, INC. investment income, net for fiscal 2023 was $211.00K.
  • ROCKWELL MEDICAL, INC. investment income, net for fiscal 2017 was $892.00, a 99.89% decline from fiscal 2016.
Period endInvestment Income, Net 3 monthInvestment Income, Net 6 monthInvestment Income, Net 9 monthInvestment Income, Net 12 month
2026-06-30$40.00K
10-Q · filed 2026-08-13
$77.00K
10-Q · filed 2026-08-13
$121.00K
derived: sum of 3 quarters · filed 2026-08-13
$176.00K
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$37.00K
10-Q · filed 2026-05-07
$81.00K
derived: sum of 2 quarters · filed 2026-05-07
$136.00K
derived: sum of 3 quarters · filed 2026-05-07
$205.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$44.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$99.00K
derived: sum of 2 quarters · filed 2026-03-26
$168.00K
derived: sum of 3 quarters · filed 2026-08-13
$234.00K
10-K · filed 2026-03-26
2025-09-30$55.00K
10-Q · filed 2025-11-12
$124.00K
derived: sum of 2 quarters · filed 2026-08-13
$190.00K
10-Q · filed 2025-11-12
$219.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$69.00K
10-Q · filed 2026-08-13
$135.00K
10-Q · filed 2026-08-13
$164.00K
derived: sum of 3 quarters · filed 2026-08-13
$194.00K
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$66.00K
10-Q · filed 2026-05-07
$95.00K
derived: sum of 2 quarters · filed 2026-05-07
$125.00K
derived: sum of 3 quarters · filed 2026-05-07
$134.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$29.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$59.00K
derived: sum of 2 quarters · filed 2026-03-26
$68.00K
derived: sum of 3 quarters · filed 2026-03-26
$92.00K
10-K · filed 2026-03-26
2024-09-30$30.00K
10-Q · filed 2025-11-12
$39.00K
derived: sum of 2 quarters · filed 2025-11-12
$63.00K
10-Q · filed 2025-11-12
$105.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$9.00K
10-Q · filed 2025-08-14
$33.00K
10-Q · filed 2025-08-14
$75.00K
derived: sum of 3 quarters · filed 2025-08-14
$131.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$24.00K
10-Q · filed 2025-05-12
$66.00K
derived: sum of 2 quarters · filed 2025-05-12
$122.00K
derived: sum of 3 quarters · filed 2025-05-12
$171.00K
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$42.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$98.00K
derived: sum of 2 quarters · filed 2025-03-20
$147.00K
derived: sum of 3 quarters · filed 2025-03-20
$211.00K
10-K · filed 2025-03-20
2023-09-30$56.00K
10-Q · filed 2024-11-12
$105.00K
derived: sum of 2 quarters · filed 2024-11-12
$169.00K
10-Q · filed 2024-11-12
2023-06-30$49.00K
10-Q · filed 2024-08-08
$113.00K
10-Q · filed 2024-08-08
2023-03-31$64.00K
10-Q · filed 2024-05-14
2022-09-30-$6.00K
10-Q · filed 2023-11-14
-$6.00K
derived: sum of 2 quarters · filed 2023-11-14
-$10.00K
10-Q · filed 2023-11-14
2022-06-30$0.00
10-Q · filed 2023-08-14
$0.00
10-Q · filed 2023-08-14
2022-03-31$0.00
10-Q · filed 2023-05-15
2021-09-30$0.00
10-Q · filed 2022-11-14
$17.00K
10-Q · filed 2022-11-14
2018-09-30$28.89K
10-Q · filed 2018-11-09
$95.00K
derived: sum of 2 quarters · filed 2018-11-09
$264.29K
10-Q · filed 2018-11-09
$445.46K
derived: sum of 4 quarters · filed 2018-11-09
2018-06-30$66.11K
10-Q · filed 2018-08-14
$235.39K
10-Q · filed 2018-08-14
$416.56K
derived: sum of 3 quarters · filed 2018-08-14
$384.81K
derived: sum of 4 quarters · filed 2018-11-09
2018-03-31$169.28K
10-Q/A · filed 2018-08-14
$350.45K
derived: sum of 2 quarters · filed 2018-08-14
$318.70K
derived: sum of 3 quarters · filed 2018-11-09
-$45.90K
derived: sum of 4 quarters · filed 2018-11-09
2017-12-31$181.17K
10-K · filed 2018-03-15
$149.42K
derived: sum of 2 quarters · filed 2018-11-09
-$215.18K
derived: sum of 3 quarters · filed 2018-11-09
$892.00
10-K · filed 2018-03-15
2017-09-30-$31.75K
10-Q · filed 2018-11-09
-$396.35K
derived: sum of 2 quarters · filed 2018-11-09
-$180.28K
10-Q · filed 2018-11-09
$27.63K
derived: sum of 4 quarters · filed 2018-11-09
2017-06-30-$364.60K
10-Q · filed 2018-08-14
-$148.53K
10-Q · filed 2018-08-14
$59.38K
derived: sum of 3 quarters · filed 2018-08-14
$248.23K
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31$216.07K
10-Q/A · filed 2018-08-14
$423.98K
derived: sum of 2 quarters · filed 2018-08-14
$612.83K
derived: sum of 3 quarters · filed 2018-08-14
$839.85K
derived: sum of 4 quarters · filed 2018-08-14
2016-12-31$207.91K
10-K · filed 2018-03-15
$396.76K
derived: sum of 2 quarters · filed 2018-03-15
$623.78K
derived: sum of 3 quarters · filed 2018-03-15
$810.34K
10-K · filed 2018-03-15
2016-09-30$188.85K
10-K · filed 2018-03-15
$415.87K
derived: sum of 2 quarters · filed 2018-03-15
$602.43K
10-Q · filed 2017-11-08
2016-06-30$227.02K
10-K · filed 2018-03-15
$413.58K
10-Q · filed 2017-08-09
2016-03-31$186.56K
10-K · filed 2018-03-15
2015-12-31$681.88K
10-K · filed 2018-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
BriaCell Therapeutics Corp. (BCTX)$0.037B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
PMGC Holdings Inc. (ELAB)United States$0.037B
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
NANOVIRICIDES, INC. (NNVC)United States$0.031B